Inspire Medical Systems Posts Q1 Loss of $0.39/Share, Revenue Tops Forecasts
INSP is trading near its 52-week low of $48.3 (7.7% above the low).
Summary
Inspire Medical Systems reported a Q1 net loss of $11.3 million, resulting in an EPS of -$0.39. Despite the loss, the company's Q1 revenue reached $204.6 million, surpassing the IBES estimate of $202 million, representing a 1.6% growth. This quarterly update follows the company's strong 2025 financial performance. While the revenue beat indicates better-than-expected top-line execution, the continued net loss will be a key focus for investors. Traders will be watching for future trends in profitability and how the company plans to leverage revenue growth to achieve positive net income.
At the time of this announcement, INSP was trading at $52.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $48.30 to $163.35. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.